RECOGNITION OF APOPTOTIC CELLS BY HUMAN MACROPHAGES - INHIBITION BY A MONOCYTE/MACROPHAGE-SPECIFIC MONOCLONAL-ANTIBODY

被引:107
作者
FLORA, PK [1 ]
GREGORY, CD [1 ]
机构
[1] UNIV BIRMINGHAM,SCH MED,DEPT IMMUNOL,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
关键词
APOPTOSIS; MACROPHAGE; RECOGNITION; 61D3; INTEGRIN;
D O I
10.1002/eji.1830241109
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cells undergoing death by apoptosis are rapidly engulfed by phagocytes in vivo, a highly efficient process which prevents leakage of potentially dangerous intracellular contents from dying cells to neighboring tissue. We have tested a panel of monoclonal antibodies (mAb) specifying a range of human monocyte/macrophage surface antigens for their capacity to inhibit the in vitro recognition of apoptotic cells by human peripheral blood monocyte-derived macrophages. The results identify the antigen defined by the 61D3 mAb, a widely-used marker of monocyte/macrophage lineage cells, as an important mediator of apoptotic cell recognition. In our system, apoptotic, but not viable, cells were recognized by the cultured macrophages and 61D3 was found to inhibit the recognition of all apoptotic cell types tested, including Ca2+ ionophore-treated or growth factor-depleted B and T lymphocyte lines, tonsillar germinal center B cells, irradiated peripheral blood lymphocytes and senescing neutrophils. Furthermore, the apoptotic cell recognition pathway specified by 61D3 could be distinguished from that involving the macrophage alpha(v) beta(3) vitronectin receptor which has been shown previously to play an important role in the recognition of apoptotic cells. These results provide further evidence that the mechanisms underlying rapid clearance of apoptotic cells involve multiple phagocyte receptors.
引用
收藏
页码:2625 / 2632
页数:8
相关论文
共 32 条
[1]  
BUCKLEY PJ, 1987, AM J PATHOL, V128, P505
[2]   THE HUMAN MONONUCLEAR PHAGOCYTE HIGH-AFFINITY FC RECEPTOR, FCRI, DEFINED BY A MONOCLONAL-ANTIBODY, 10.1 [J].
DOUGHERTY, GJ ;
SELVENDRAN, Y ;
MURDOCH, S ;
PALMER, DG ;
HOGG, N .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) :1453-1459
[3]  
DUVALL E, 1985, IMMUNOLOGY, V56, P351
[4]  
ELLIS RE, 1991, GENETICS, V129, P79
[5]  
FADOK VA, 1992, J IMMUNOL, V149, P4029
[6]  
FADOK VA, 1992, J IMMUNOL, V148, P2207
[7]  
FLORA PLK, 1994, LEUCOCYTE TYPING, V5
[8]   DIFFERENT EPSTEIN-BARR VIRUS-B CELL-INTERACTIONS IN PHENOTYPICALLY DISTINCT CLONES OF A BURKITTS-LYMPHOMA CELL-LINE [J].
GREGORY, CD ;
ROWE, M ;
RICKINSON, AB .
JOURNAL OF GENERAL VIROLOGY, 1990, 71 :1481-1495
[9]   ACTIVATION OF EPSTEIN-BARR-VIRUS LATENT GENES PROTECTS HUMAN B-CELLS FROM DEATH BY APOPTOSIS [J].
GREGORY, CD ;
DIVE, C ;
HENDERSON, S ;
SMITH, CA ;
WILLIAMS, GT ;
GORDON, J ;
RICKINSON, AB .
NATURE, 1991, 349 (6310) :612-614
[10]   REGULATION OF CELL-SURVIVAL IN BURKITT-LYMPHOMA - IMPLICATIONS FROM STUDIES OF APOPTOSIS FOLLOWING COLD-SHOCK TREATMENT [J].
GREGORY, CD ;
MILNER, AE .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (03) :419-426